Howland; David S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Howland; David S..The latest application filed is for "antagonist antibodies against gdf-8".

Company Profile

0.11.11

Howland; David S. - Philadelphia PA
Howland; David S. - Yardley PA
Howland; David S. - Princeton NJ
Howland; David S. - Exton PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Add-on orders for delivery Grant 10,043,149 - Iacono , et al. August 7, 2	2018-08-07
Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8 Grant 9,926,368 - Walsh , et al. March 27, 2	2018-03-27
Antagonist Antibodies Against Gdf-8 App 20150152176 - Walsh; Frank S. ; et al.	2015-06-04
Method for treating sarcopenia using antagonist antibodies against GDF-8 Grant 8,956,608 - Walsh , et al. February 17, 2	2015-02-17
Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders App 20140086920 - Walsh; Frank S. ; et al.	2014-03-27
Method for treating cachexia using antagonist antibodies against GDF-8 Grant 8,496,934 - Walsh , et al. July 30, 2	2013-07-30
Method For Treating Cachexia Using Antagonist Antibodies Against Gdf-8 App 20130156767 - Walsh; Frank S. ; et al.	2013-06-20
Polynucleotides encoding antagonist antibodies against GDF-8 Grant 8,372,625 - Walsh , et al. February 12, 2	2013-02-12
Method for treating muscular dystrophy using antagonist antibodies against GDF-8 Grant 8,349,327 - Walsh , et al. January 8, 2	2013-01-08
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20120016106 - Walsh; Frank S. ; et al.	2012-01-19
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20120003212 - WALSH; FRANK S. ; et al.	2012-01-05
Target Sequences And Methods To Identify The Same, Useful In Treatment Of Neurodegenerative Diseases App 20110105587 - Fishcher; David Frederik ; et al.	2011-05-05
Molecular Targets And Compounds, And Methods To Identify The Same, Useful In The Treatment Of Neurodegenerative Diseases App 20110077283 - Fischer; David Frederik ; et al.	2011-03-31
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders Grant 7,910,107 - Walsh , et al. March 22, 2	2011-03-22
Antagonist antibodies against GDF-8 Grant 7,888,486 - Walsh , et al. February 15, 2	2011-02-15
Antagonist Antibodies Against Gdf-8 And Uses In Treatment Of Als And Other Gdf-8 Associated Disorders App 20090285827 - Walsh; Frank S. ; et al.	2009-11-19
Transgenic animal App 20080168571 - Young; Kathleen ; et al.	2008-07-10
Transgenic animal Grant 7,262,336 - Young , et al. August 28, 2	2007-08-28
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders App 20070087000 - Walsh; Frank S. ; et al.	2007-04-19
Transgenic animal App 20040025197 - Young, Kathleen ; et al.	2004-02-05
Secretion sequence for the production of a heterologous protein in yeast Grant 5,521,086 - Scott , et al. May 28, 1	1996-05-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.